Put Bioprocessing and Engineering to Work
Mammalian bioprocessing is the foundation of biologics production in the pharmaceutical industry. This course covers a range of fundamental knowledge spanning the entire drug substance manufacturing process. Students taking this course will learn core biological and engineering principles for both cell culture and purification operations. Unit operations for cell culture and purification steps will be described and analyzed. Practical methods for scaling-up manufacturing process will also be described. Additionally, an overview of product quality, analytical, and regulatory topics pertinent to bioprocessing will be provided.
Lectures for this workshop are given by industry professionals who will provide insight into how this knowledge is applied to modern biologics production. This detailed yet concise course is appropriate for early to mid-career professionals as well as students looking to gain relevant skills in mammalian bioprocessing. The course is also a great way for individuals in supporting functions such as automation, instrumentation, and supply chain to gain a deeper understanding of the manufacturing processes they support.
This section is the full week of cell culture bioprocessing. Please note that there are separate 3-day options during the same week for those who prefer to attend the upstream or downstream individually.
2019 Keynote Talks
- Role of Cell Culture in the Commercialization of Biologics, Antonio Grillo-Lopez, Former CMO, IDEC
- Cell Culture for Biosimilar Products, Julio Baez, Former CSO, Cipla BioTec
- Cell Culture for Biotherapeutic Protein & Vaccine Products, Kara Calhoun, Director, Genentech
- Manufacturing of cGMP Viral Vectors for Human Gene Therapies, Daniel Gibbs, Director, Salk Institute
- Cell Culture Biomanufacturing - Strategy from Product Operations Perspectives, Eric Fallon, Director, Genentech
- Cary Opel, Senior Scientist, Gilead Sciences, Inc.
- Tom Fletcher, Scientific Director, Fujifilm Irvine Scientific
- Nathan Lewis, Associate Professor, UC San Diego
- David Razafsky, Senior Scientist, MilliporeSigma
- Kenneth Clapp, Senior Manager, GE Healthcare Life Sciences
Regulatory and Analytical:
- Scott Rosenthal, Senior Director, Genentech
- Joseph Stark, Development Scientist, MilliporeSigma
- Oscar Bernal, Development Scientist, MilliporeSigma
- April Wheeler, Technology Manager, MilliporeSigma
- Alana Bartelle, Director, Genentech
- Alexandre Ambrogelly, Director, Gilead
Note: This workshop will take place at Gilead Sciences, Inc., in Oceanside, CA, and is open to attendees over 18 years of age. Closed-toe shoes are required at all times.
Course Number: BIOL-40349
Credit: 4.00 unit(s)
+ Expand All
9/16/2019 - 9/20/2019